INTECH Investment Management’s TG Therapeutics TGTX Stock Holding History

INTECH Investment Management’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.85M	Buy	124,646 +15,776	+14%	+$646K	0.06%	264
2026 Q1	$3.62M	Sell	108,870 -44,262	-29%	-$1.32M	0.04%	434
2025 Q4	$4.56M	Buy	153,132 +82,253	+116%	+$2.69M	0.04%	406
2025 Q3	$2.56M	Sell	70,879 -4,665	-6%	-$154K	0.02%	644
2025 Q2	$2.72M	Sell	75,544 -10,983	-13%	-$409K	0.03%	580
2025 Q1	$3.41M	Buy	86,527 +14,694	+20%	+$494K	0.04%	464
2024 Q4	$2.16M	Buy	71,833 +23,570	+49%	+$676K	0.02%	673
2024 Q3	$1.13M	Buy	+48,263	New	+$1.05M	0.01%	740

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

INTECH Investment Management's TGTX Position: Q2 2026 in Review

INTECH Investment Management increased its TG Therapeutics (TGTX) stake by 14% in Q2 2026, buying an estimated $646K and bringing the position to 124,646 shares worth $6.85M. The position accounts for 0.06% of the portfolio, ranked #264.

INTECH Investment Management first reported a position in TGTX in Q3 2024 and has held it in 8 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

INTECH Investment Management held 124,646 shares of TG Therapeutics worth $6.85M as of Q2 2026.
INTECH Investment Management bought 15,776 TG Therapeutics shares in Q2 2026, an estimated $646K.
TG Therapeutics made up 0.06% of INTECH Investment Management's portfolio in Q2 2026, its #264 holding.
INTECH Investment Management first reported a position in TG Therapeutics in Q3 2024 and has held it in 8 quarters since.
427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.